Ulcerative colitis (subacute manifestations) - infliximab

Summary

Infliximab is not recommended for people with subacute, moderately to severely active ulcerative colitis. Subacute ulcerative colitis is defined as ulcerative colitis that would normally be managed without needing to stay in hospital overnight or having urgent surgery.

Documents

For healthcare professionals

• TA140 Ulcerative colitis (subacute manifestations) - infliximab: quick reference guide
• TA140 Ulcerative colitis (subacute manifestations) - infliximab: NICE guidance
• TA140 Ulcerative colitis (subacute manifestations) - infliximab: NICE guidance (MS Word format)

For patients, carers and the public

• TA140 Ulcerative colitis (subacute manifestations) - infliximab: understanding NICE guidance
• TA140 Ulcerative colitis (subacute manifestations) - infliximab: understanding NICE guidance (MS Word format)
• TA140 Infliximab ar gyfer llid briwiol y coluddyn lledlym - deall canllawiau NICE (fformat MS Word)

Background information

• 2008/031 NICE appraisal of infliximab for ulcerative colitis

Implementing this guidance

Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:

• Ulcerative colitis (subacute manifestations) - infliximab: audit support
• Ulcerative colitis (subacute manifestations) - infliximab: costing statement